MARLA COUTURE: Open Payments
NPI 1699775403 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$990 in 59 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $123 · 2025 $990
Food & beverage: $990
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $220 |
| ABBVIE INC. | 11 | $149 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $130 |
| PFIZER INC. | 8 | $128 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $82 |
| Novo Nordisk Inc | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Exact Sciences Corporation | 2 | $31 |
| Biogen, Inc. | 1 | $27 |
Products named: Kerendia, JARDIANCE, ELIQUIS, QULIPTA, MOUNJARO, XIFAXAN, Wegovy, The Cologuard Plus Collection Kit.
Industry payments across AL — which companies pay providers there.
